CAS 127779-20-8: Saquinavir
Description:Saquinavir is an antiretroviral medication primarily used in the treatment of HIV/AIDS. It belongs to the class of protease inhibitors, which work by inhibiting the protease enzyme, crucial for the viral replication process. Saquinavir is characterized by its relatively low bioavailability when taken orally, necessitating its administration in combination with other antiretroviral agents to enhance its efficacy. The compound is typically presented as a mesylate salt, which improves its solubility and stability. Chemically, Saquinavir features a complex structure that includes multiple chiral centers, contributing to its pharmacological activity. It is known for its side effects, which can include gastrointestinal disturbances and potential interactions with other medications due to its metabolism via the cytochrome P450 system. Saquinavir's development marked a significant advancement in HIV treatment, and it is often used in combination therapy to achieve better viral suppression and improve patient outcomes.
Formula:C38H50N6O5
InChI:InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1
InChI key:InChIKey=QWAXKHKRTORLEM-UGJKXSETSA-N
SMILES:O=C(N)CC(NC(=O)C=1N=C2C=CC=CC2=CC1)C(=O)NC(CC=3C=CC=CC3)C(O)CN4CC5CCCCC5CC4C(=O)NC(C)(C)C
- Synonyms:
- Ro 31-8959
- Butanediamide, N1-[3-[3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, [3S-[2[1R*(R*),2S*],3α,4aβ,8aβ]]-
- (S)-N-[(αS)-α-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide
- (2S)-N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide
- Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-
- N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide
- N~1~-{(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide
